What does this research mean for the field?

Question

Accepted Answer

Chronic administration of intrathecal morphine provides opiate-receptor-mediated pain relief for terminal cancer patients for at least 3 months, and delta-ligands like DADL show significant analgesic activity even in morphine-tolerant spinal cords. Novelty: ClaimNovelty.CONFIRMATORY. Consensus alignment: ConsensusAlignment.NEUTRAL.

Treatment of Chronic Pain of Malignant Origin with Intrathecal Opiates

Discussion

Member takes

Implication

Key Points

Cite This Study